BioCardia, Inc. Contract Liability (Deferred Revenue)
BioCardia, Inc. (BCDA) had Contract Liability (Deferred Revenue) of $0 as of 2023-12-31, per its 10-K filed 2024-03-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2024-03-27
- 2023-12-31: Contract with Customer, Liability, Current $0.00.
- 2023-09-30: Contract with Customer, Liability, Current $0.00.
- 2023-06-30: Contract with Customer, Liability, Current $333.00K.
- 2023-03-31: Contract with Customer, Liability, Current $340.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-27 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 |
| 2023-06-30 | $333.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $340.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $341.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $378.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-10 |
| 2022-03-31 | $948.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $847.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $886.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.42M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.18M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $683.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $90.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $104.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $104.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $102.00K 10-Q · filed 2020-11-10 |
| 2019-09-30 | $252.00K 10-Q · filed 2019-11-19 |
| 2019-06-30 | $104.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $118.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $112.00K 10-K · filed 2020-04-09 |
| 2017-12-31 | $61.00K 10-K · filed 2019-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |